2023
DOI: 10.1007/s11010-023-04707-1
|View full text |Cite
|
Sign up to set email alerts
|

Emerging role of lipophagy in liver disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 152 publications
0
1
0
Order By: Relevance
“…However, NLRP3 inflammasome activation can also influence autophagy [ 52 ], leading to caspase-1-dependent mitophagy blockade in macrophages, resulting in dysfunctional mitochondria and an exacerbated inflammatory response [ 53 ]. Moreover, balanced autophagy can effectively mitigate lipid accumulation [ 54 , 55 ]. Therefore, we hypothesize that silibinin may selectively inhibit NLRP3 inflammasome activation to exhibit anti-inflammatory effects and alleviate hepatocyte injury in the presence of DCA-induced inflammation in hepatocytes.…”
Section: Discussionmentioning
confidence: 99%
“…However, NLRP3 inflammasome activation can also influence autophagy [ 52 ], leading to caspase-1-dependent mitophagy blockade in macrophages, resulting in dysfunctional mitochondria and an exacerbated inflammatory response [ 53 ]. Moreover, balanced autophagy can effectively mitigate lipid accumulation [ 54 , 55 ]. Therefore, we hypothesize that silibinin may selectively inhibit NLRP3 inflammasome activation to exhibit anti-inflammatory effects and alleviate hepatocyte injury in the presence of DCA-induced inflammation in hepatocytes.…”
Section: Discussionmentioning
confidence: 99%